00995nas a2200289 4500000000100000008004100001260001700042653001200059653002200071653003000093653001100123653001400134653002300148653002300171653001200194653002500206653001800231653001300249653000900262100001200271700001600283245010700299300001000406490000700416520026800423022001400691 1980 d c1980 Mar-Apr10aDapsone10aDrug Combinations10aDrug Therapy, Combination10aHumans10aIsoniazid10aIsonicotinic Acids10aLeprostatic Agents10aleprosy10aMycobacterium leprae10aProthionamide10aRifampin10aSkin1 aColin M1 aMontaigne E00a[Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)]. a157-90 v403 a
Thirty lepromatous patients were treated during 3 months. If clinical condition was notably improved, the bacillary index and the morphologic index remained almost un-changed and the histo-pathological features, advanced concurrently to the clinic aspects.
a0025-682X